Skip to main content

10.05.2024 | Assisted Reproduction Technologies

Is a day 7 blastocyst predictive of the reproductive potential of sibling day 5 and day 6 blastocysts?

verfasst von: Jennia Michaeli, Natalie Ge, Ella Huszti, Ellen M. Greenblatt

Erschienen in: Journal of Assisted Reproduction and Genetics

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To explore if a day 7 blastocyst is predictive of the reproductive potential of sibling day 5 or day 6 blastocysts?

Methods

Retrospective cohort of autologous frozen embryo transfers (FET), February 2019 to April 2022. Cycles divided into groups 1 to 5, according to the day of embryo cryopreservation and the presence of a day 7 blastocyst sibling within the cohort: group 1/group 2—day 5 blastocyst without/with a day 7 sibling, group 3/group 4—day 6 blastocyst without/with a day 7 sibling, group 5—day 7 blastocyst. Clinical, ongoing pregnancy and miscarriage rates, cycle, and patient characteristics are reported. Multivariable generalized estimating equations (GEE) logistic regression analysis accounts for confounders and assesses the effect of a sibling day 7 blastocyst on ongoing pregnancy rates of day 5 or day 6 blastocyst FETs.

Results

Ongoing pregnancy rates are 38.4%, 59.5%, 30.8%, 32.7%, and 4.4% in groups 1–5, respectively. When correcting for maternal age, number of oocytes retrieved and discarded per cohort, and ploidy, embryos cryopreserved on either day 6 or day 7 have reduced odds of ongoing pregnancy after FET compared to day 5 blastocysts (OR = 0.76, IQR [0.61–0.95], p-value = 0.01). However, the presence of a day 7 sibling does not significantly affect odds of ongoing pregnancy of day 5 or day 6 blastocysts compared to the same-day blastocyst without a day 7 sibling (p-value = 0.20 and 0.46, respectively). This finding is consistent within both the Preimplantation Genetic Testing for Aneuploidy (PGT-A) unscreened and screened (euploid) embryo subgroups.

Conclusions

Day of embryo cryopreservation significantly affects ongoing pregnancy rates. However, day 7 embryos within a cohort do not affect the reproductive potential of sibling day 5 and day 6 blastocysts, suggesting that slow embryo development is an embryo-specific trait.
Literatur
2.
Zurück zum Zitat Hammond ER, Cree LM, Morbeck DE. Should extended blastocyst culture include Day 7? Hum Reprod. 2018;33:991–7.CrossRefPubMed Hammond ER, Cree LM, Morbeck DE. Should extended blastocyst culture include Day 7? Hum Reprod. 2018;33:991–7.CrossRefPubMed
5.
Zurück zum Zitat Tiegs AW, Sun L, Patounakis G, Scott RT. Worth the wait day 7 blastocysts have lower euploidy rates but similar sustained implantation rates as Day 5 and day 6 blastocysts. Hum Reprod. 2019;34:1632–9.CrossRefPubMed Tiegs AW, Sun L, Patounakis G, Scott RT. Worth the wait day 7 blastocysts have lower euploidy rates but similar sustained implantation rates as Day 5 and day 6 blastocysts. Hum Reprod. 2019;34:1632–9.CrossRefPubMed
6.
Zurück zum Zitat Whitney JB, Balloch K, Anderson RE, Nugent N, Schiewe MC. Day 7 blastocyst euploidy supports routine implementation for cycles using preimplantation genetic testing. J Bras Reprod Assist. 2019;23:45–50. Whitney JB, Balloch K, Anderson RE, Nugent N, Schiewe MC. Day 7 blastocyst euploidy supports routine implementation for cycles using preimplantation genetic testing. J Bras Reprod Assist. 2019;23:45–50.
8.
Zurück zum Zitat Corti L, Cermisoni GC, Alteri A, Pagliardini L, Ambrosini G, Andrisani A, et al. Clinical outcomes deriving from transfer of blastocysts developed in Day 7: a systematic review and Meta-analysis of frozen-thawed IVF cycles. Reprod Sci. 2022;29:43–53.CrossRefPubMed Corti L, Cermisoni GC, Alteri A, Pagliardini L, Ambrosini G, Andrisani A, et al. Clinical outcomes deriving from transfer of blastocysts developed in Day 7: a systematic review and Meta-analysis of frozen-thawed IVF cycles. Reprod Sci. 2022;29:43–53.CrossRefPubMed
10.
Zurück zum Zitat Doherty LF, Martin JR, Kayisli U, Sakkas D, Patrizio P. Fresh transfer outcome predicts the success of a subsequent frozen transfer utilizing blastocysts of the same cohort. Reprod Biomed Online. 2014;28:204–8.CrossRefPubMed Doherty LF, Martin JR, Kayisli U, Sakkas D, Patrizio P. Fresh transfer outcome predicts the success of a subsequent frozen transfer utilizing blastocysts of the same cohort. Reprod Biomed Online. 2014;28:204–8.CrossRefPubMed
11.
Zurück zum Zitat Practice Committee of the American Society for Reproductive Medicine. T, Practice Committee of the Society for Assisted Reproductive Technology T. Revised guidelines for human embryology and andrology laboratories. Fertil Steril. 2008;90. Practice Committee of the American Society for Reproductive Medicine. T, Practice Committee of the Society for Assisted Reproductive Technology T. Revised guidelines for human embryology and andrology laboratories. Fertil Steril. 2008;90.
14.
Zurück zum Zitat Desai N, Ploskonka S, Goodman L, Attaran M, Goldberg JM, Austin C, et al. Delayed blastulation, multinucleation, and expansion grade are independently associated with live-birth rates in frozen blastocyst transfer cycles. Fertil Steril. 2016;106:1370–8.CrossRefPubMed Desai N, Ploskonka S, Goodman L, Attaran M, Goldberg JM, Austin C, et al. Delayed blastulation, multinucleation, and expansion grade are independently associated with live-birth rates in frozen blastocyst transfer cycles. Fertil Steril. 2016;106:1370–8.CrossRefPubMed
15.
Zurück zum Zitat Poulsen V, Ingerslev HJ, Kirkegaard K. Elective embryo transfers on Day 6 reduce implantation compared with transfers on Day 5. Hum Reprod. 2017;32:1238–43.CrossRefPubMed Poulsen V, Ingerslev HJ, Kirkegaard K. Elective embryo transfers on Day 6 reduce implantation compared with transfers on Day 5. Hum Reprod. 2017;32:1238–43.CrossRefPubMed
17.
19.
Zurück zum Zitat Yang H, Yang Q, Dai S, Li G, Jin H, Yao G, et al. Comparison of differences in development potentials between frozen-thawed D5 and D6 blastocysts and their relationship with pregnancy outcomes. J Assist Reprod Genet. 2016;33:865–72.CrossRefPubMedPubMedCentral Yang H, Yang Q, Dai S, Li G, Jin H, Yao G, et al. Comparison of differences in development potentials between frozen-thawed D5 and D6 blastocysts and their relationship with pregnancy outcomes. J Assist Reprod Genet. 2016;33:865–72.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Hernandez-Nieto C, Lee JA, Slifkin R, Sandler B, Copperman AB, Flisser E. What is the reproductive potential of day 7 euploid embryos. Hum Reprod. 2019;34:1697–706.CrossRefPubMed Hernandez-Nieto C, Lee JA, Slifkin R, Sandler B, Copperman AB, Flisser E. What is the reproductive potential of day 7 euploid embryos. Hum Reprod. 2019;34:1697–706.CrossRefPubMed
Metadaten
Titel
Is a day 7 blastocyst predictive of the reproductive potential of sibling day 5 and day 6 blastocysts?
verfasst von
Jennia Michaeli
Natalie Ge
Ella Huszti
Ellen M. Greenblatt
Publikationsdatum
10.05.2024
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-024-03129-2

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.